Nurix Therapeutics Inc NRIX Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc (NRIX) Financials

Nurix Therapeutics Inc (NRIX)

16.73

-0.86

(-4.89%)

Closed February 18 3:00PM

Delayed by 15 minutes

16.73

0.00

( 0.00% )

Pre Market: 5:24AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End November 29 2024	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-41.536	-48.519	-19.638	-26.845	-40.37	-37.275	-37.772
Return on Equity (%)	51.174	45.894	-37.189	-37.053	-55.839	-57.101	-53.216
Return on Invested Capital (%)	-185.835	-6562.044	-47.112	-58.858	-84.171	-73.274	-59.975
Operating Margin (%)	-23.822	-68.97	-357.896	-393.489	-466.927	-186.977	-354.358
Net Profit Margin (%)	-25.176	-69.738	-242.66	-393.929	-466.927	-186.977	-354.853
Book Value Per Share	1.096	-0.883	7.469	7.664	6.438	4.134	7.44
Earnings Per Share	-0.91	-2.012	-1.113	-2.624	-3.823	-2.968	-2.733
Cash Per Share	2.471	3.228	3.071	1.802	1.367	1.126	1.553
Working Capital Per Share	0.755	2.153	6.533	5.482	5.253	4.3	7.391
Operating Profit Per Share	3.615	2.885	0.459	0.666	0.819	1.587	0.77
EBIT Per Share	-0.861	-1.99	-1.641	-2.621	-3.823	-2.968	-2.729
EBITDA Per Share	-0.861	-1.99	-1.641	-2.621	-3.823	-2.968	-2.729
Free Cash Flow Per Share	-1.045	-2.077	-1.052	-2.56	-3.677	-2.95	-2.733

Liquidity Ratios

Year End November 29 2024	2018	2019	2020	2021	2022	2023	2024
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	10.36M	10.79M	38.87M	44.66M	47.17M	N/A	N/A

Key Stats and Ratios

Year End November 29 2024	Feb 2023	May 2023	Aug 2023	Nov 2023	Feb 2024	May 2024	Aug 2024	Nov 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	48.2M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-321.112	N/A	N/A	N/A	-249.792	N/A	N/A	N/A
Net Profit Margin (%)	-321.112	N/A	N/A	N/A	-250.335	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.27B
Price to Earnings Ratio	-6.56
Price to Sales Ratio	23.27
Price to Cash Ratio	11.54
Price to Book Ratio	2.41
Dividend Yield	-

Share Statistics

Shares Outstanding	75.89M
Average Volume (1 week)	578.23k
Average Volume (1 Month)	638.05k
52 Week Change	75.74%
52 Week High	29.56
52 Week Low	9.52

More Ratios Coming Soon!

Nurix Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions